Influence of interleukin-8 challenge in the nasal mucosa in atopic and nonatopic subjects

American Journal of Respiratory and Critical Care Medicine

Volumn 150, Issue 4, 1994, Pages 1108-1113

  Douglass, Jo A ^a   Dhami, Deepak ^b   Gurr, Caroline E ^b   Bulpitt, Mark ^b   Shute, Janis K ^b   Howarth, Peter H ^b   Lindley, Ivan J ^b   Church, Martin K ^b   Holgate, Stephen T ^b  

^a ALFRED HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; CD3 ANTIGEN; HISTAMINE; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 8; LEUKOCYTE ELASTASE;

ADULT; ARTICLE; ATOPY; BASOPHIL; BIOPSY; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NEUTROPHIL; NOSE AIRWAY RESISTANCE; NOSE MUCOSA; ORAL DRUG ADMINISTRATION; PRICK TEST; PRIORITY JOURNAL; T LYMPHOCYTE; TOPICAL DRUG ADMINISTRATION;

EID: 0028006976     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.150.4.7921444     Document Type: Article

References (38)

1. Oppenheim JJ, Zacharie COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991;9:617-48.
2. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL-1). J Immunol 1987;139:788-93.
3. Mielke V, Bauman JGJ, Sticherling M, Ibs T, Zomershoe AG, Seligmann K, Henneicke HH, Schroder JM, Sterry W, Christophers E. Detection of neutrophil-activating peptide NAP/IL-8 mRNA in human recombinant IL-1α- and human recombinant tumor necrosis factor-α-stimulated human dermal fibroblasts. J Immunol 1990;144:153-161.
4. Strieter RM, Kunkel SL, Showell HJ, Remick DG, Phan SH, Ward PA, Marks RM. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS and IL-1β. Science 1989;243:1467-9.
5. Nakamura H, Yoshimura K, Jaffe HA, Crystal RG. Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 1991;266: 19611-7.
6. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil activating peptide 1/interleukin-8. J Exp Med 1991;173:771-4.
7. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Appella E, Kung HF, Leonard EJ, Oppenheim JJ. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J Exp Med 1988;167:1883-93.
8. Djeu JY, Matsushima K, Oppenheim JJ, Shiotsuki K, Blanchard DK. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol 1990;144:2205-10.
9. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990;171:1155-62.
10. Paccaud J-P, Schifferli JA, Baggiolini M. NAP-1/IL-8 induces up-regulation of CR1 receptors on human neutrophil leukocytes. Biochem Biophys Res Commun 1990;166:187-92.
11. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil-activating peptide (NAP-1) is also chemotactic for T-lymphocytes. Science 1989;243:1464-6.
12. Dahinden CA, Kurimoto Y, De Weck A, Lindley I, Dewald B, Baggiolini M. The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils. J Exp Med 1989;170:1787-92.
13. Warringa RAJ, Koenderman L, Kok PTM, Kreukniet J, Bruijnzeel PLB. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3. Blood 1991; 77:2694-700.
14. Rolfe MW, Kunkel SL, Standiford TJ, Chensue SW, Allen RM, Evanoff HL, Phan SH, Streiter RM. Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol 1991;5:493-501.
15. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch III JP, Toews GB, Westwick J, Strieter RM. Interleukin-8 gene expression by a pulmonary epithelial cell line. J Clin Invest 1990;86:1945-53.
16. Marini M, Vittori E, Hollemborg H, Mattoli S. Expression of the potent inflammatory cytokines granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8 in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992;89:1001-9.
17. Griffiths CEM, Barker JNWN, Kunkel S, Nickoloff BJ. Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-α) in allergic contact dermatitis (Rhus dermatitis). Br J Dermatol 1991;124:519-26.
18. Mahida YR, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ. Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci 1992;82:273-5.
19. Van Zee K, De Forge L, Fischer E, Marano M, Kenrey J, Remick D, Leury S, Moldawer L. IL-8 in septic shock, endotoxaemia and after IL-1 administration. J Immunol 1991;146:3478-82.
20. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991:17:17-23.
21. Millar A, Brown Z, Spiteri M, Westwick J. Interleukin-8 (IL-8) is produced by the bronchoalveolar lavage cell population from patients with active but not inactive sarcoidosis. Am Rev Respir Dis (Suppl) 1992;145:A231.
22. Assadullahi TP, Church MK, Dai Y, Hill CM, Lambert EJ, Postle AD, Shute JK, Warner JO. Interleukin-8 concentrations are elevated in children with cystic fibrosis (CF). Am Rev Respir Dis (Suppl) 1992;145:A118.
23. Donnelly SC, Streiter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollock AJ, Haslett C. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341:643-7.
24. Bachert C, Seyfarth M, Plumpe S, Holtappels G. Proinflammatory cytokines in nasal lavage fluid after allergen challenge. J Allergy Clin Immunol 1992;89(2):A179.
25. Terada N, Konno A, Tada H, Shirotori K, Ishikawa K, Togawa K. The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa. J Allergy Clin Immunol 1992;90:160-8.
26. Colditz I, Zwahlen R, Dewald B, Baggiolini M. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. Am J Pathol 1989;134:755-60.
27. Rampart M, Van Damme J, Zonnekeyn L, Herman AG. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol 1989;135:21-5.
28. Leonard EJ, Yoshimura T, Tanaka S, Raffeld M. Neutrophil recruitment by intradermally injected neutrophil attractant/activating protein-1 in human subjects. J Invest Dermatol 1991;96:690-4.
29. Medhurst AD, Westwick J, Piper PJ. hrlL-8-induced responsiveness in guinea pig perfused lungs. Ann NY Acad Sci 1991;629:419-20.
30. Lindley I, Aschauer H, Seifert J-M, Lam C, Brunowsky W, Kownatzki E, Thelen M, Peveri P, Dewald B, von Tscharner V, Walz A, Baggiolini M. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci USA 1988;85:9199-203.
31. Gleeson MJ, Youlton LJF, Shelton DM, Siodak M, Eiser NM, Wengraf CL. Assessment of nasal airways patency: a comparison of four methods. Clin Otolarynol 1986;11:99-107.
32. 9]brakykinin in atopic rhinitic and normal volunteers. J Physiol (Lond) 1990;437:557-87.
33. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten KM, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992;176:1381-6.
34. Tai PC, Spry CJF, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984;309:182-4.
35. Dewald B, Rindler-Ludwig R, Bretz UC, Baggiolini M. Subcellular localization and heterogeneity of neutral proteases in neutrophilic polymorphonuclear leukocytes. J Exp Med 1975;141:709-23.
36. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet a granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989;84:92-9.
37. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Apella E, Oppenheim JJ, Leonard EJ. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defence cytokines. Proc Natl Acad Sci USA 1987;84:9233-7.
38. Leonard EJ, Skeel A, Yoshimura T, Noer K, Kutvirt S, Van Epps D. Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J Immunol 1990;144:1323-30.